Skip to main content
. 2020 Dec 9;10:21583. doi: 10.1038/s41598-020-78395-y

Figure 2.

Figure 2

Viability, population doubling time, growth rate, and total cell yield of cultured human nasal septal chondrocytes (hNSCs). (a) The mean percentage of viable GF-treated hNSCs based on the trypan blue exclusion test. (b) Population doubling time was significantly lower in GF-treated hNSCs compared with the control medium of 2%HS starting from P1 to P6. (c) The growth rate (cells/cm2/day) was significantly higher in GF-treated hNSCs compared with the control medium of 2%HS starting from P1 to P6. (d) Total cumulative cell yield of GF-treated hNSCs and the control medium 2%HS were 3.04 × 1010 vs. 2.73 × 108 cells respectively. P—passage number. GF—Growth Factors. (*) represents a statistically significant difference when p < 0.05 as analysed by one-way ANOVA. Values are presented as mean ± SEM, (n = 6).